Optimal drug treatment regimens for HIV depend on adherence
Authors:
- 7 June 2007
- journal article
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 246 (3) , 499-509
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cellsJournal of Theoretical Biology, 2006
- Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges?Proceedings Of The Royal Society B-Biological Sciences, 2005
- Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patientsJournal of The Royal Society Interface, 2005
- Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAIDS, 2005
- Time to Virological Failure of 3 Classes of Antiretrovirals after Initiation of Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study GroupThe Journal of Infectious Diseases, 2004
- Paradoxes of adherence and drug resistance to HIV antiretroviral therapyJournal of Antimicrobial Chemotherapy, 2004
- Increasing Impact of Chronic Viral Hepatitis on Hospital Admissions and Mortality among HIV-Infected PatientsAIDS Research and Human Retroviruses, 2001
- Adherence, Side Effects and Efficacy of Stavudine plus Lamivudine plus Nelfinavir in Treatment-experienced HIV-infected PatientsJournal of Infection, 2000
- Adherence and drug resistance: predictions for therapy outcomeProceedings Of The Royal Society B-Biological Sciences, 2000
- Barriers to and Facilitators of HIV-Positive Patients' Adherence to Antiretroviral Treatment RegimensAIDS Patient Care and STDs, 2000